Does BOTULINUM TOXIN TYPE A Cause Muscular weakness? 436 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 436 reports of Muscular weakness have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 11.7% of all adverse event reports for BOTULINUM TOXIN TYPE A.
436
Reports of Muscular weakness with BOTULINUM TOXIN TYPE A
11.7%
of all BOTULINUM TOXIN TYPE A reports
352
Deaths
320
Hospitalizations
How Dangerous Is Muscular weakness From BOTULINUM TOXIN TYPE A?
Of the 436 reports, 352 (80.7%) resulted in death, 320 (73.4%) required hospitalization, and 293 (67.2%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
Yes, Muscular weakness is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Muscular weakness Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE